Synthetic Biology · Q3 2026 · Implementation Playbook

Design went public. Capacity got expensive. Here's the order of operations.

H1 is what has a date on it: OMB's list is due December 18 and your 2027 automation capex is being approved now. H2 is the capability that takes 12 to 24 months to build and cannot be bought under deadline. H3 is the structural shift that decides whether you still have a business model in 2031.

H1Next 90 daysH212–24 monthsH33–5 years
H1
Horizon 1 · The next 90 days

Three things expire in this window: the pre-list mapping window before December 18, the 2027 capex cycle, and your current price on vector and fill-finish capacity.

Autonomous Lab Access

Members

BIOSECURE + Supply Chain

Members

Manufacturing Position

Members

CEO Agenda · across all three forces

Members

CFO Agenda · across all three forces

Members
The playbook continues with the moves by role and horizons 2 and 3